SOST and chronic kidney disease: In patients with CKD, higher serum sclerostin levels are associated with more severe carotid artery atherosclerosis, which may represent a compensatory response aimed at limiting vascular calcification through the inhibition of the Wnt/β-catenin pathway [33,34].